Compare GNI Group Ltd. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
JPY 157,989 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.31
-18.51%
3.16
Revenue and Profits:
Net Sales:
5,526 Million
(Quarterly Results - Mar 2026)
Net Profit:
-3,376 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-17.2%
0%
-17.2%
6 Months
0.96%
0%
0.96%
1 Year
-26.72%
0%
-26.72%
2 Years
8.26%
0%
8.26%
3 Years
67.8%
0%
67.8%
4 Years
91.12%
0%
91.12%
5 Years
20.78%
0%
20.78%
GNI Group Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
22.39%
EBIT Growth (5y)
-205.04%
EBIT to Interest (avg)
3.09
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
0.52
Tax Ratio
8.02%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.87%
ROE (avg)
8.25%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.47
EV to EBIT
-68.18
EV to EBITDA
-134.43
EV to Capital Employed
4.71
EV to Sales
5.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-6.90%
ROE (Latest)
-14.59%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
5,526.00
7,483.00
-26.15%
Operating Profit (PBDIT) excl Other Income
-2,177.00
-1,967.00
-10.68%
Interest
588.00
552.00
6.52%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-3,376.00
-5,074.00
33.46%
Operating Profit Margin (Excl OI)
-449.90%
-303.90%
-14.60%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -26.15% vs 5.32% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 33.46% vs -2,002.51% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
26,840.00
23,611.70
13.67%
Operating Profit (PBDIT) excl Other Income
-1,157.00
436.70
-364.94%
Interest
1,743.00
1,452.40
20.01%
Exceptional Items
-532.00
-148.30
-258.73%
Consolidate Net Profit
-7,150.00
-9.60
-74,379.17%
Operating Profit Margin (Excl OI)
-85.50%
-23.10%
-6.24%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 13.67% vs -9.22% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -74,379.17% vs -100.10% in Dec 2024
About GNI Group Ltd. 
GNI Group Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






